Jeannette N. Stankowski
AstraZeneca (Brazil)(BR)Alexion Pharma (Switzerland)(CH)
Publications by Year
Research Areas
Amyotrophic Lateral Sclerosis Research, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Mitochondrial Function and Pathology, Multiple Sclerosis Research Studies
Most-Cited Works
- → C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits(2015)400 cited
- → Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress(2014)338 cited
- → C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins(2016)320 cited
- → Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease(2014)268 cited
- → Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis(2017)266 cited
- → (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylation(2015)181 cited
- → Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy(2019)163 cited
- → Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia(2009)130 cited
- → Acetylation: a new key to unlock tau’s role in neurodegeneration(2014)130 cited
- → The lysosomal protein cathepsin L is a progranulin protease(2017)114 cited